• Publications
  • Influence
Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.
Currently approved influenza vaccines predominantly protect through antibodies directed against the highly variable glycoprotein hemagglutinin (HA), necessitating annual redesign and formulationExpand
  • 40
  • 2
Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection.
Recombinant, Escherichia coli-derived outer membrane vesicles (rOMVs), which display heterologous protein subunits, have potential as a vaccine adjuvant platform. One drawback to rOMVs is theirExpand
  • 23
  • 1
  • PDF
RIT Staff Council Minutes of February 11, 2010
AGENDA: Vision 2025, Chair's Report, Committee Reports, Vote for Open E.C. Seat, Discussion with Barb Ross, Motion: To Approve Policy on Non-Exempt Institute Volunteerism, Old / New Business